63 results
Page 3 of 4
8-K
EX-99.1
r66kzbks8bmg
6 May 20
Axcella Announces Positive Top-Line Data from AXA1125-003 Clinical Study Showing Multifactorial Activity in Adult Subjects with NAFLD
8:09am
DEFA14A
jmgko 6e4xyav
3 Apr 20
Additional proxy soliciting materials
4:19pm
DEF 14A
i2c8ggoxcf7ogq1lw35
3 Apr 20
Definitive proxy
4:15pm
DRS
mb0i2d
3 Apr 20
Draft registration statement
12:00am
10-K
yisx4wssm7iqqun5qc
23 Mar 20
Annual report
4:12pm
8-K
EX-10.1
eyini1
25 Nov 19
Axcella Strengthens Executive Team with Key Addition and Promotion
8:11am
10-Q
xr1lu
20 Jun 19
Quarterly report
5:03pm
424B4
lc105 9fapaxr2wic
9 May 19
Prospectus supplement with pricing info
4:29pm
S-1/A
EX-1.1
k2zuf979dmb
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
EX-10.2
muzgax9d
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
EX-10.10
39lu0019mpv
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
EX-10.12
k9gdm8m6
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
m3j921v6
30 Apr 19
IPO registration (amended)
6:06am
CORRESP
6z34y in1rr8ss
24 Apr 19
Correspondence with SEC
12:00am
S-1
EX-4.2
quom3xsy41 jahzmn59
12 Apr 19
IPO registration
7:02am